[go: up one dir, main page]

GB202414347D0 - Antisense oligonucleotides for the treatment of liver disease - Google Patents

Antisense oligonucleotides for the treatment of liver disease

Info

Publication number
GB202414347D0
GB202414347D0 GBGB2414347.1A GB202414347A GB202414347D0 GB 202414347 D0 GB202414347 D0 GB 202414347D0 GB 202414347 A GB202414347 A GB 202414347A GB 202414347 D0 GB202414347 D0 GB 202414347D0
Authority
GB
United Kingdom
Prior art keywords
treatment
liver disease
antisense oligonucleotides
antisense
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2414347.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB2414347.1A priority Critical patent/GB202414347D0/en
Publication of GB202414347D0 publication Critical patent/GB202414347D0/en
Ceased legal-status Critical Current

Links

GBGB2414347.1A 2024-09-30 2024-09-30 Antisense oligonucleotides for the treatment of liver disease Ceased GB202414347D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2414347.1A GB202414347D0 (en) 2024-09-30 2024-09-30 Antisense oligonucleotides for the treatment of liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2414347.1A GB202414347D0 (en) 2024-09-30 2024-09-30 Antisense oligonucleotides for the treatment of liver disease

Publications (1)

Publication Number Publication Date
GB202414347D0 true GB202414347D0 (en) 2024-11-13

Family

ID=93378637

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2414347.1A Ceased GB202414347D0 (en) 2024-09-30 2024-09-30 Antisense oligonucleotides for the treatment of liver disease

Country Status (1)

Country Link
GB (1) GB202414347D0 (en)

Similar Documents

Publication Publication Date Title
AU2024246572A1 (en) Antisense oligonucleotides for the treatment of liver disease
GB202502333D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202414347D0 (en) Antisense oligonucleotides for the treatment of liver disease
AU2023390632A1 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202318087D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202304438D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202418028D0 (en) Antisense oligonucleotides for the treatment of fatty liver disease
GB202405813D0 (en) Antisense oligonucleotides for the treatment of fatty liver disease
GB202502170D0 (en) Antisense oligonucleotides for the treatment of disease
GB202410081D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
CA3286425A1 (en) Antisense oligonucleotides for the treatment of liver disease
GB202502332D0 (en) Antisense oligonucleotides for the treatment of liver cancer
GB202502189D0 (en) Antisense oligonucleotides for the treatment of liver cancer
GB202306756D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202218585D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202404661D0 (en) Antisense oligoncleotides for the treatment of liver disease
GB202405143D0 (en) Antisense oligonucleotides for the treatment of poly-q disease
IL319679A (en) Antisense oligonucleotides for the treatment of canavan disease
GB202502460D0 (en) Antisense oligonucleotides for the treatment of cancer
GB202400404D0 (en) Antisense oligonucleotides for the treatment of polg-related disorders
GB202417415D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
GB202418430D0 (en) Antisense oligonucleotides for the treatment of migrane
GB202306060D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202418144D0 (en) Antisense oligonucleotides for the treatment of parkinson's disease
GB202217580D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)